awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q52582181-5B9AE4E7-5E1F-4A0F-8188-08378CB37C42
Q52582181-5B9AE4E7-5E1F-4A0F-8188-08378CB37C42
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52582181-5B9AE4E7-5E1F-4A0F-8188-08378CB37C42
Synergistic anti-proliferative effect of mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.
P2860
Q52582181-5B9AE4E7-5E1F-4A0F-8188-08378CB37C42
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52582181-5B9AE4E7-5E1F-4A0F-8188-08378CB37C42
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d71fd55437ad549dc6f4dac36576cd534ae7d2bc
P2860
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study